Letter to the Editor: “Improving Risk Analysis for Fatal Thrombosis in COVID-19: A Call for Targeted Anticoagulation” regarding: “Incidence, Predictors, and Outcomes of Venous and Arterial Thrombosis in COVID-19: A Nationwide Inpatient Analysis” by Agrawal et al. Heart Lung Circ. 2024;33(11):1563–73

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart, Lung and Circulation Pub Date : 2024-11-01 DOI:10.1016/j.hlc.2024.10.002

Chia Siang Kow MPharm , Dinesh Sangarran Ramachandram MSc , Syed Shahzad Hasan PhD , Kaeshaelya Thiruchelvam PhD

引用次数: 0

致编辑的信："改进 COVID-19 致命性血栓形成的风险分析：关于 "COVID-19 中静脉和动脉血栓形成的发生率、预测因素和预后：呼吁有针对性的抗凝治疗 "的编辑信函：Agrawal等人的 "COVID-19中静脉和动脉血栓形成的发生率、预测因素和结果：Agrawal等人撰写的 "COVID-19中静脉和动脉血栓形成的发生率、预测因素和结果：全国住院患者分析"，《心肺循环》，2024;33(11):1563-73。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart, Lung and Circulation CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

4.50

自引率

3.80%

发文量

912

审稿时长

11.9 weeks

期刊介绍： Heart, Lung and Circulation publishes articles integrating clinical and research activities in the fields of basic cardiovascular science, clinical cardiology and cardiac surgery, with a focus on emerging issues in cardiovascular disease. The journal promotes multidisciplinary dialogue between cardiologists, cardiothoracic surgeons, cardio-pulmonary physicians and cardiovascular scientists.